Optimizing Treatment Effects on OSA-related Clinical and Patient-centered Outcomes Among Blacks

Sponsor
NYU Langone Health (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03354520
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD) (NIH)
0
1
3

Study Details

Study Description

Brief Summary

The study is to maximize efficacy of message delivery to achieve desired Obstructive sleep apnea (OSA) adherence goal. Newly diagnosed black patients (n=390, all genders) from participating sleep clinics will be randomly exposed to either the individually tailored or standard OSA messages. Investigators will look at an effective and scalable intervention to improve OSA-related outcomes: a) clinical CVD and brain health measures and b) patient-centered outcomes. Patient-centered and adherence data will be captured via REDCap, enabling real-time application of data-driven decision rules while implementing the intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Tailored Videos
  • Behavioral: OSA Treatment
  • Behavioral: Standard Videos
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Optimizing Treatment Effects on OSA-related Clinical and Patient-centered Outcomes Among Blacks
Actual Study Start Date :
Jun 18, 2021
Actual Primary Completion Date :
Jun 18, 2021
Actual Study Completion Date :
Jun 18, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Tailored Videos

Behavioral: Tailored Videos
web-based OSA messages (videos featuring role models and coaching advice using motivational enhancement) addressing OSA barriers within a health literacy framework--to decrease cognitive load and render messages understandable and actionable. OSA messages were tailored based on focus group data in the previous study (group tailoring).

Active Comparator: Standard Videos

Behavioral: Standard Videos
Patients in the control arm will also receive an iPad, providing access to standard online OSA health information (e.g., National Sleep Foundation) in an equivalent dose as in the intervention arm using pre-selected automatic alerts to access the website

Active Comparator: OSA Treatment

Behavioral: OSA Treatment
Web-based platform delivering messages promoting OSA self-efficacy. . All patients will view the introductory video, followed by the video cluster: Sleep, Health, and Well-Being; Sleep-Heart Health; Lifestyle Changes; and Sleep Hygiene.

Outcome Measures

Primary Outcome Measures

  1. Change from Baseline OSA Self-Efficacy Scale Score to 6 Months Score [2 Months and 6 Months]

    The mean of the nonmissing item responses was calculated for each of the 3 subscales: Perceived Risk, Outcome Expectancies, and Treatment Self-Efficacy. Using this mean-weighted score prevents the distortion of the score from missing responses. Factor 1 (Risk Perception consisting of 8 questions); Factor 2 (Outcome Expectancy consisting of 9 items) and Factor 3 (Treatment Self Efficacy consisting of 9 items) are given a potential score of 1-4.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Self-reported race/ethnicity as African American, African, Caribbean or black

  • Accessible by phone

  • No plans to move away within the year

  • OSA diagnosis, consent, including permission to release medical data

  • Physician-diagnosed medical conditions.

Exclusion Criteria:
  • Progressive illnesses in which disability or death is expected within 1 year

  • Impaired cognitive/ functional ability precluding participation

  • Intention to move within the same year of enrollment

  • Family member currently enrolled

Contacts and Locations

Locations

Site City State Country Postal Code
1 New York University School of Medicine New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health
  • National Institute on Minority Health and Health Disparities (NIMHD)

Investigators

  • Principal Investigator: Girardin Jean-Louis, PhD, NYU Langone Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT03354520
Other Study ID Numbers:
  • 17-01097
First Posted:
Nov 28, 2017
Last Update Posted:
Feb 9, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 9, 2022